7.51
Precedente Chiudi:
$7.37
Aprire:
$7.37
Volume 24 ore:
155.99K
Relative Volume:
0.91
Capitalizzazione di mercato:
$281.37M
Reddito:
$128.45M
Utile/perdita netta:
$6.54M
Rapporto P/E:
150.20
EPS:
0.05
Flusso di cassa netto:
$-8.79M
1 W Prestazione:
-5.65%
1M Prestazione:
+11.09%
6M Prestazione:
+16.43%
1 anno Prestazione:
+7.59%
Lifecore Biomedical Inc Stock (LFCR) Company Profile
Nome
Lifecore Biomedical Inc
Settore
Telefono
(952) 368-4300
Indirizzo
3515 LYMAN BOULEVARD, CHASKA
Confronta LFCR con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
|
LFCR
Lifecore Biomedical Inc
|
7.51 | 276.13M | 128.45M | 6.54M | -8.79M | 0.05 |
|
ZTS
Zoetis Inc
|
120.73 | 51.07B | 9.40B | 2.65B | 2.24B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.30 | 44.42B | 29.63B | 260.53M | 5.51B | 0.0788 |
|
HLN
Haleon Plc Adr
|
9.865 | 42.75B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
24.16 | 27.86B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
472.28 | 20.44B | 3.08B | 1.24B | 1.07B | 25.61 |
Lifecore Biomedical Inc Stock (LFCR) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-09-04 | Iniziato | KeyBanc Capital Markets | Sector Weight |
| 2025-05-21 | Iniziato | William Blair | Outperform |
| 2024-09-05 | Iniziato | Craig Hallum | Buy |
| 2024-08-28 | Downgrade | Barrington Research | Outperform → Mkt Perform |
| 2023-03-20 | Downgrade | Stephens | Overweight → Equal-Weight |
Lifecore Biomedical Inc Borsa (LFCR) Ultime notizie
Lifecore Biomedical at Stephens Annual Investment Conference: Strategic Growth Path By Investing.com - Investing.com Canada
Can Lifecore Biomedical Inc. stock surprise with earnings upsideQuarterly Performance Summary & AI Powered Buy and Sell Recommendations - newser.com
Will Lifecore Biomedical Inc. (LDE) stock benefit from sector leadership2025 Breakouts & Breakdowns & Technical Pattern Recognition Alerts - newser.com
Will Lifecore Biomedical Inc. stock benefit from green energy trendsProfit Target & Daily Oversold Stock Bounce Ideas - newser.com
Is Lifecore Biomedical Inc. stock ready for breakoutStop Loss & Short-Term High Return Strategies - newser.com
What candlestick patterns are forming on Lifecore Biomedical Inc.July 2025 Selloffs & Safe Entry Momentum Tips - newser.com
Should I hold or sell Lifecore Biomedical Inc. stock in 2025July 2025 Recap & Capital Protection Trade Alerts - newser.com
How to interpret RSI for Lifecore Biomedical Inc. stock2025 Bull vs Bear & Consistent Return Investment Signals - newser.com
How Lifecore Biomedical Inc. stock benefits from strong dollarMarket Rally & Expert-Curated Trade Recommendations - newser.com
Why pension funds invest in Lifecore Biomedical Inc. (LDE) stockBull Run & Technical Confirmation Trade Alerts - newser.com
Will Lifecore Biomedical Inc. (LDE) stock see insider accumulation - newser.com
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Lifecore Biomedical, Inc. (LFCR) And Encourages Shareholders to Reach Out - ACCESS Newswire
Lifecore Biomedical at Jefferies London: Strategic Growth Unveiled By Investing.com - Investing.com Canada
Lifecore Biomedical, Inc. Announces Fiscal Year Change and Strategic Developments - TradingView
Real time pattern detection on Lifecore Biomedical Inc. stockQuarterly Risk Review & Weekly Chart Analysis and Trade Guides - newser.com
Will Lifecore Biomedical Inc. (LDE) stock gain from lower interest ratesQuarterly Market Summary & Risk Managed Investment Strategies - newser.com
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Lifecore Biomedical, Inc. (LFCR) and Encourages Shareholders to Learn More About the Investigation - ACCESS Newswire
Lifecore Biomedical (NASDAQ:LFCR) Adds US$54m to Market Cap in the Past 7 Days, Though Investors From Five Years Ago Are Still Down 19% - 富途牛牛
Market reaction to Lifecore Biomedical Inc.’s recent news2025 Sector Review & Safe Entry Point Alerts - newser.com
Is it too late to sell Lifecore Biomedical Inc.Market Growth Review & Capital Protection Trading Alerts - newser.com
Is Lifecore Biomedical Inc. stock affected by interest rate hikesMarket Activity Report & Daily Risk Controlled Trade Plans - Fundação Cultural do Pará
Is Lifecore Biomedical Inc. (LDE) stock undervalued after correctionWeekly Loss Report & Consistent Return Strategy Ideas - newser.com
Will Lifecore Biomedical Inc. (LDE) stock recover faster than industryQuarterly Profit Summary & Reliable Intraday Trade Alerts - newser.com
Lifecore Biomedical, Inc. (LFCR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Lifecore Biomedical Inc Azioni (LFCR) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Lifecore Biomedical Inc Azioni (LFCR) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| English Aron R. | 10% Owner |
May 28 '25 |
Sale |
7.12 |
150,419 |
1,071,555 |
264,180 |
| English Aron R. | 10% Owner |
May 23 '25 |
Sale |
6.75 |
96,137 |
649,386 |
1,554,103 |
| English Aron R. | 10% Owner |
May 13 '25 |
Sale |
7.00 |
12,334 |
86,353 |
1,650,240 |
| English Aron R. | 10% Owner |
May 12 '25 |
Sale |
7.03 |
45,698 |
321,426 |
1,662,574 |
| English Aron R. | 10% Owner |
May 08 '25 |
Sale |
7.00 |
5,098 |
35,693 |
1,708,972 |
| English Aron R. | 10% Owner |
May 09 '25 |
Sale |
7.00 |
700 |
4,900 |
1,708,272 |
| English Aron R. | 10% Owner |
May 05 '25 |
Sale |
7.08 |
24,543 |
173,831 |
1,730,618 |
| English Aron R. | 10% Owner |
May 07 '25 |
Sale |
7.01 |
15,847 |
111,099 |
1,714,070 |
| English Aron R. | 10% Owner |
May 06 '25 |
Sale |
7.05 |
701 |
4,940 |
1,729,917 |
| Josephs Paul | Chief Executive Officer |
Jan 08 '25 |
Buy |
5.74 |
17,000 |
97,580 |
559,717 |
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):